1º hcpa oncologyhematology 2016 v03 · centro cultural de belém (sala amália rodrigues), lisbon,...
TRANSCRIPT
www.hcpa.pt
2016 LisbonPORTUGALCentro Cultural de Belém
September
15•16•17
ADVANCEDCOURSEon Oncology/HematologyTherapy 2016
MónicaNave
ADVANCEDCOURSEon Oncology/HematologyTherapy 2016
2016 LisbonPORTUGALCentro Cultural de Belém
September
15•16•17
LEARNING OBJECTIVES
CO-CHAIRS
\ To understand the basic principles of Medical Oncology\ To understand how the main tumour types are approached in the clinic
from diagnosis to therapy\ To get closed to the practice of Oncology in a multidisciplinary setting\ To capture the importance of a molecular definition of tumours in
the context of a modern precision Medicine
NazaréRosado
The volume of oncology drug information is expanding exponentially and the need for more emphasis on medication safety monitoring and assurance is imperative. There is an increasing need for specialized and well-trained oncology professionals and it is forecasted that the demand for highly motivated and properly credentialed professional teams in oncology will continue to increase for the foreseeable future!This HCPA Advanced Course on Oncology/Hematology aims to dotate professionals with the actual best practice and create opm-portunities for knowledge sharing and collaboration!!
FACULTY
\ Hospital Pharmacy Specialist- Ordem dos Farmacêuticos
\ Lead pharmacist Aseptic Serviceat Hospital da Luz,Portugal
\ Oncologist at Hospital da Luz, Portugal
\ Member of the Portuguese Medical Society (Oncology)Portugal
MónicaNave
NazaréRosado
\ MD, Medical Oncology\ Coordenadora da Unidade de Pulmão, \ Responsável da área médica da Unidade
de Sarcomas, IPOPORTOFGPortugal
\ MD, PhD, Post-Doctoral\ Vice-Director of Instituto de Medicina
Molecular\ Associate Professor at Faculdade
de Medicina da Universidade de LisboaPortugal
BrunoSilva-Santos
MartaSoares
\ John Valgus, PharmD, BCOP, CPP\ Clinical Specialist, clinic based
- Hematology/Oncology Clinic\ Clinical Assistant Professor
- UNC Eshelman School of Pharmacyand UNC School of MedicineUnited States
JohnValgus
2016 LisbonPORTUGALCentro Cultural de Belém
September
15•16•17
\ MD, Medical Oncology\ IPOLFG, E.P.E.
Portugal
EmanuelGouveia
\ MD, Medical Oncology\ Hospital Beatriz Ângelo, Lisboa
Portugal
FábioLopes
\ Clinical Pharmacist\ Clinica Universidad de Navarra\ Grupo de Farmacia Oncológica de la SEFH
Spain
AzucenaAldaz
\ MD\ Haematologist at Hospital São João, Porto\ PhD Student of the Cancer Drug Resistance
Group at IPATIMUPPortugal
RuiBergantim
\ MD\ Haematologist at Fundação
Champalimaud, Lisboa\ Faculdade de Ciências Médicas,
Universidade Nova de LisboaPortugal
CristinaJoão
FACULTY
2016 LisbonPORTUGALCentro Cultural de Belém
September
15•16•17
THE IMPORTANCE OF A MULTIDISCIPLINARY APPROACHMonica Nave, MDNazaré, PharmD
A PRACTICAL REVIEW OF CANCER DIAGNOSIS,STAGING, PROGNOSIS AND THERAPYMonica Nave, MD
SYSTEMIC ANTICANCER THERAPY: CLASSIC CHEMOTHERAPYAND TARGETED THERAPYNazaré, PharmD
CANCER IMMUNOTHERAPYBruno Silva Santos, PhD
THERAPY MANAGEMENT ON SOLID TUMORSNSCLCMarta Soares, MD, PTJohn Valgus, PharmD, US
\ Diagnosis and staging \ Adjuvant and neoadjuvant setting \ New approaches oral therapies and immunotherapy \ Managing toxicities\ Clinical Cases Session
DAY 1 - 15 Sep
SCIENTIFICPROGRAM
ADVANCEDCOURSEon Oncology/HematologyTherapy 2016
2016 LisbonPORTUGALCentro Cultural de Belém
September
15•16•17
DAY 3 - 17 Sep
THERAPY MANAGEMENT ON HEMATOLOGIC MALIGNANCIESMyelodisplasic SyndromesAzucena Aldaz, PharmD, PhD, SP
, MD, US
\ Classification, features, diagnosis and treatment options\ New molecules\ Supportive therapy IMMUNOTHERAPY IN HEMATOONCOLOGYMonoclonal Antibodies, Checkpoint Inhibitors and Cart CellsCristina João, MD, PT Small Molecules (Anti-BTK and Anti-PI3K),Imunomodulation and TransplantationRui Bergantim, MD, PT
TBA ( to be announced)
ADVANCEDCOURSEon Oncology/HematologyTherapy 2016
2016 LisbonPORTUGALCentro Cultural de Belém
September
15•16•17
DAY 2 - 16 Sep
THERAPY MANAGEMENT ON SOLID TUMORSMelanomaEmanuel Gouveia, MD, PTJohn Valgus, PharmD, US
\ Immunotherapy and Target therapy\ The best choice and best sequence
CANCER OF UNKNOWN PRIMARY: A DIAGNOSTICAND THERAPEUTIC CHALLENGEFábio Lopes, MD, PT
ARE PARP INHIBITORS READY FOR PRIME TIME?Mónica Nave, MD, PT
\ Managing symptoms and toxicities\ Clinical Cases Session
ADVANCEDCOURSEon Oncology/HematologyTherapy 2016
SCIENTIFIC COMMITTEEMónica Nave, MD, Hospital da luz, PTMª Nazaré Rosado, PharmD, Hospital da luz, PTFernando FernandezLlimos, FFUL, PT
ORGANISING COMMITTEEAndreia Duarte, HCPA • Rui Rodrigues, HCPA
EVENT OFFICIAL AGENCY
Perfect ExperiencesRNAVT 3965Rua da Junqueira 200 1º1300-346Portugal
T 213 616 720F 213 616 729E [email protected]
flgx
REGISTRATION (Limited to 30 places) Registration values2350 euros (VAT included)
Venue Centro Cultural de Belém (Sala Amália Rodrigues), Lisbon, Portugal
Secretariat
Social eventsClosure dinner on Friday, September 16th
2016 LisbonPORTUGALCentro Cultural de Belém
September
15•16•17
www.hcpa.pt
OUR MISSION IS
PROMOTING EXCELLENCE IN MEDICINES MANAGEMENTThe central objective of HCPA is to promote a complete training program aiming excellence, based on the current best practices of the various areas related to hospital medicines.
Our trainings are delivered by recognized national and international health professionals with proven experience.
is a brand owned by Perfect Experiences.